APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Analgesic Gel Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global OTC Analgesic Gel Drug Market Analysis and Forecast 2026-2032

21 December 2025194 pages

Choose your research edition.

Industry ResearchOTC Analgesic Gel Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Analgesic Gel Drug Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal OTC Analgesic Gel Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Analgesic Gel Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Analgesic Gel Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global OTC Analgesic Gel Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for OTC Analgesic Gel Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for OTC Analgesic Gel Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for OTC Analgesic Gel Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for OTC Analgesic Gel Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of OTC Analgesic Gel Drug include China Biopharmaceutical Co., Ltd., Jiangsu Innovent Biologics Co., Ltd., Job Care Pharmaceutical Group Co., Ltd., Hunan Jiudian Pharmaceutical Co., Ltd., Teikoku Pharma, RB Health, PERNATON, MIKASA SEIYAKU CO.,LTD and Lead Chemical CO., Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for OTC Analgesic Gel Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of OTC Analgesic Gel Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for OTC Analgesic Gel Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the OTC Analgesic Gel Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global OTC Analgesic Gel Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for OTC Analgesic Gel Drug revenue, projected growth trends, production technology, application and end-user industry.

OTC Analgesic Gel Drug Segment by Company

China Biopharmaceutical Co., Ltd.

Jiangsu Innovent Biologics Co., Ltd.

Job Care Pharmaceutical Group Co., Ltd.

Hunan Jiudian Pharmaceutical Co., Ltd.

Teikoku Pharma

RB Health

PERNATON

MIKASA SEIYAKU CO.,LTD

Lead Chemical CO., Ltd

Kowa Company

Haleon

OTC Analgesic Gel Drug Segment by Type

Patches

Ointments

OTC Analgesic Gel Drug Segment by Application

Online Sales

Offline Sales

OTC Analgesic Gel Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Analgesic Gel Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Analgesic Gel Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Analgesic Gel Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of OTC Analgesic Gel Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of OTC Analgesic Gel Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OTC Analgesic Gel Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global OTC Analgesic Gel Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Patches Major Player Table 3. Ointments Major Player Table 4. Global OTC Analgesic Gel Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Online Sales Major Player Table 6. Offline Sales Major Player Table 7. OTC Analgesic Gel Drug Industry Trends Table 8. OTC Analgesic Gel Drug Industry Drivers Table 9. OTC Analgesic Gel Drug Industry Opportunities and Challenges Table 10. OTC Analgesic Gel Drug Industry Restraints Table 11. Global OTC Analgesic Gel Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global OTC Analgesic Gel Drug Market Size by Region (2021-2026) & (US$ Million) Table 13. Global OTC Analgesic Gel Drug Market Share by Region (2021-2026) Table 14. Global OTC Analgesic Gel Drug Market Size by Region (2027-2032) & (US$ Million) Table 15. Global OTC Analgesic Gel Drug Market Share by Region (2027-2032) Table 16. Global OTC Analgesic Gel Drug Revenue by Players (US$ Million) & (2021-2026) Table 17. Global OTC Analgesic Gel Drug Revenue Market Share by Players (2021-2026) Table 18. Global OTC Analgesic Gel Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global OTC Analgesic Gel Drug Key Players Headquarters & Area Served Table 20. Global OTC Analgesic Gel Drug Players, Product Type & Application Table 21. Global OTC Analgesic Gel Drug Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global OTC Analgesic Gel Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global OTC Analgesic Gel Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global OTC Analgesic Gel Drug Revenue by Type (2021-2026) & (US$ Million) Table 26. Global OTC Analgesic Gel Drug Revenue by Type (2027-2032) & (US$ Million) Table 27. Global OTC Analgesic Gel Drug Revenue Market Share by Type (2021-2026) Table 28. Global OTC Analgesic Gel Drug Revenue Market Share by Type (2027-2032) Table 29. Global OTC Analgesic Gel Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global OTC Analgesic Gel Drug Revenue by Application (2021-2026) & (US$ Million) Table 31. Global OTC Analgesic Gel Drug Revenue by Application (2027-2032) & (US$ Million) Table 32. Global OTC Analgesic Gel Drug Revenue Market Share by Application (2021-2026) Table 33. Global OTC Analgesic Gel Drug Revenue Market Share by Application (2027-2032) Table 34. China Biopharmaceutical Co., Ltd. Company Information Table 35. China Biopharmaceutical Co., Ltd. Business Overview Table 36. China Biopharmaceutical Co., Ltd. OTC Analgesic Gel Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. China Biopharmaceutical Co., Ltd. OTC Analgesic Gel Drug Product Portfolio Table 38. China Biopharmaceutical Co., Ltd. Recent Development Table 39. Jiangsu Innovent Biologics Co., Ltd. Company Information Table 40. Jiangsu Innovent Biologics Co., Ltd. Business Overview Table 41. Jiangsu Innovent Biologics Co., Ltd. OTC Analgesic Gel Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Jiangsu Innovent Biologics Co., Ltd. OTC Analgesic Gel Drug Product Portfolio Table 43. Jiangsu Innovent Biologics Co., Ltd. Recent Development Table 44. Job Care Pharmaceutical Group Co., Ltd. Company Information Table 45. Job Care Pharmaceutical Group Co., Ltd. Business Overview Table 46. Job Care Pharmaceutical Group Co., Ltd. OTC Analgesic Gel Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Job Care Pharmaceutical Group Co., Ltd. OTC Analgesic Gel Drug Product Portfolio Table 48. Job Care Pharmaceutical Group Co., Ltd. Recent Development Table 49. Hunan Jiudian Pharmaceutical Co., Ltd. Company Information Table 50. Hunan Jiudian Pharmaceutical Co., Ltd. Business Overview Table 51. Hunan Jiudian Pharmaceutical Co., Ltd. OTC Analgesic Gel Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Hunan Jiudian Pharmaceutical Co., Ltd. OTC Analgesic Gel Drug Product Portfolio Table 53. Hunan Jiudian Pharmaceutical Co., Ltd. Recent Development Table 54. Teikoku Pharma Company Information Table 55. Teikoku Pharma Business Overview Table 56. Teikoku Pharma OTC Analgesic Gel Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Teikoku Pharma OTC Analgesic Gel Drug Product Portfolio Table 58. Teikoku Pharma Recent Development Table 59. RB Health Company Information Table 60. RB Health Business Overview Table 61. RB Health OTC Analgesic Gel Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. RB Health OTC Analgesic Gel Drug Product Portfolio Table 63. RB Health Recent Development Table 64. PERNATON Company Information Table 65. PERNATON Business Overview Table 66. PERNATON OTC Analgesic Gel Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. PERNATON OTC Analgesic Gel Drug Product Portfolio Table 68. PERNATON Recent Development Table 69. MIKASA SEIYAKU CO.,LTD Company Information Table 70. MIKASA SEIYAKU CO.,LTD Business Overview Table 71. MIKASA SEIYAKU CO.,LTD OTC Analgesic Gel Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. MIKASA SEIYAKU CO.,LTD OTC Analgesic Gel Drug Product Portfolio Table 73. MIKASA SEIYAKU CO.,LTD Recent Development Table 74. Lead Chemical CO., Ltd Company Information Table 75. Lead Chemical CO., Ltd Business Overview Table 76. Lead Chemical CO., Ltd OTC Analgesic Gel Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Lead Chemical CO., Ltd OTC Analgesic Gel Drug Product Portfolio Table 78. Lead Chemical CO., Ltd Recent Development Table 79. Kowa Company Company Information Table 80. Kowa Company Business Overview Table 81. Kowa Company OTC Analgesic Gel Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Kowa Company OTC Analgesic Gel Drug Product Portfolio Table 83. Kowa Company Recent Development Table 84. Haleon Company Information Table 85. Haleon Business Overview Table 86. Haleon OTC Analgesic Gel Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Haleon OTC Analgesic Gel Drug Product Portfolio Table 88. Haleon Recent Development Table 89. North America OTC Analgesic Gel Drug Revenue by Type (2021-2026) & (US$ Million) Table 90. North America OTC Analgesic Gel Drug Revenue by Type (2027-2032) & (US$ Million) Table 91. North America OTC Analgesic Gel Drug Revenue by Application (2021-2026) & (US$ Million) Table 92. North America OTC Analgesic Gel Drug Revenue by Application (2027-2032) & (US$ Million) Table 93. North America OTC Analgesic Gel Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America OTC Analgesic Gel Drug Revenue by Country (2021-2026) & (US$ Million) Table 95. North America OTC Analgesic Gel Drug Revenue by Country (US$ Million) & (2027-2032) Table 96. Europe OTC Analgesic Gel Drug Revenue by Type (2021-2026) & (US$ Million) Table 97. Europe OTC Analgesic Gel Drug Revenue by Type (2027-2032) & (US$ Million) Table 98. Europe OTC Analgesic Gel Drug Revenue by Application (2021-2026) & (US$ Million) Table 99. Europe OTC Analgesic Gel Drug Revenue by Application (2027-2032) & (US$ Million) Table 100. Europe OTC Analgesic Gel Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe OTC Analgesic Gel Drug Revenue by Country (2021-2026) & (US$ Million) Table 102. Europe OTC Analgesic Gel Drug Revenue by Country (US$ Million) & (2027-2032) Table 103. China OTC Analgesic Gel Drug Revenue by Type (2021-2026) & (US$ Million) Table 104. China OTC Analgesic Gel Drug Revenue by Type (2027-2032) & (US$ Million) Table 105. China OTC Analgesic Gel Drug Revenue by Application (2021-2026) & (US$ Million) Table 106. China OTC Analgesic Gel Drug Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia OTC Analgesic Gel Drug Revenue by Type (2021-2026) & (US$ Million) Table 108. Asia OTC Analgesic Gel Drug Revenue by Type (2027-2032) & (US$ Million) Table 109. Asia OTC Analgesic Gel Drug Revenue by Application (2021-2026) & (US$ Million) Table 110. Asia OTC Analgesic Gel Drug Revenue by Application (2027-2032) & (US$ Million) Table 111. Asia OTC Analgesic Gel Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia OTC Analgesic Gel Drug Revenue by Region (US$ Million) & (2021-2026) Table 113. Asia OTC Analgesic Gel Drug Revenue by Region (US$ Million) & (2027-2032) Table 114. SAMEA OTC Analgesic Gel Drug Revenue by Type (2021-2026) & (US$ Million) Table 115. SAMEA OTC Analgesic Gel Drug Revenue by Type (2027-2032) & (US$ Million) Table 116. SAMEA OTC Analgesic Gel Drug Revenue by Application (2021-2026) & (US$ Million) Table 117. SAMEA OTC Analgesic Gel Drug Revenue by Application (2027-2032) & (US$ Million) Table 118. SAMEA OTC Analgesic Gel Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. SAMEA OTC Analgesic Gel Drug Revenue by Country (2021-2026) & (US$ Million) Table 120. SAMEA OTC Analgesic Gel Drug Revenue by Country (US$ Million) & (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. OTC Analgesic Gel Drug Image Figure 2. Global OTC Analgesic Gel Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Analgesic Gel Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Patches Image Figure 5. Ointments Image Figure 6. Global OTC Analgesic Gel Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global OTC Analgesic Gel Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Online Sales Image Figure 9. Offline Sales Image Figure 10. Global OTC Analgesic Gel Drug Market Size (US$ Million) & (2021-2032) Figure 11. Global OTC Analgesic Gel Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global OTC Analgesic Gel Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global OTC Analgesic Gel Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global OTC Analgesic Gel Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global OTC Analgesic Gel Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global OTC Analgesic Gel Drug Revenue Market Share by Type (2021-2032) Figure 18. Global OTC Analgesic Gel Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global OTC Analgesic Gel Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global OTC Analgesic Gel Drug Revenue Market Share by Application (2021-2032) Figure 21. North America OTC Analgesic Gel Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America OTC Analgesic Gel Drug Revenue Share by Type (2021-2032) Figure 23. North America OTC Analgesic Gel Drug Revenue Share by Application (2021-2032) Figure 24. North America OTC Analgesic Gel Drug Revenue Share by Country (2021-2032) Figure 25. United States OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe OTC Analgesic Gel Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe OTC Analgesic Gel Drug Revenue Share by Type (2021-2032) Figure 30. Europe OTC Analgesic Gel Drug Revenue Share by Application (2021-2032) Figure 31. Europe OTC Analgesic Gel Drug Revenue Share by Country (2021-2032) Figure 32. Germany OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China OTC Analgesic Gel Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China OTC Analgesic Gel Drug Revenue Share by Type (2021-2032) Figure 42. China OTC Analgesic Gel Drug Revenue Share by Application (2021-2032) Figure 43. Asia OTC Analgesic Gel Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia OTC Analgesic Gel Drug Revenue Share by Type (2021-2032) Figure 45. Asia OTC Analgesic Gel Drug Revenue Share by Application (2021-2032) Figure 46. Asia OTC Analgesic Gel Drug Revenue Share by Region (2021-2032) Figure 47. Japan OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA OTC Analgesic Gel Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA OTC Analgesic Gel Drug Revenue Share by Type (2021-2032) Figure 55. SAMEA OTC Analgesic Gel Drug Revenue Share by Application (2021-2032) Figure 56. SAMEA OTC Analgesic Gel Drug Revenue Share by Country (2021-2032) Figure 57. Brazil OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt OTC Analgesic Gel Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Patches
  • Ointments
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • China Biopharmaceutical Co., Ltd.
  • Jiangsu Innovent Biologics Co., Ltd.
  • Job Care Pharmaceutical Group Co., Ltd.
  • Hunan Jiudian Pharmaceutical Co., Ltd.
  • Teikoku Pharma
  • RB Health
  • PERNATON
  • MIKASA SEIYAKU CO.,LTD
  • Lead Chemical CO., Ltd
  • Kowa Company
  • Haleon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 OTC Analgesic Gel Drug Market by Type
  3. 1.2.1 Global OTC Analgesic Gel Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Patches
  5. 1.2.3 Ointments
  6. 1.3 OTC Analgesic Gel Drug Market by Application
  7. 1.3.1 Global OTC Analgesic Gel Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Online Sales
  9. 1.3.3 Offline Sales
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 OTC Analgesic Gel Drug Market Dynamics
  1. 2.1 OTC Analgesic Gel Drug Industry Trends
  2. 2.2 OTC Analgesic Gel Drug Industry Drivers
  3. 2.3 OTC Analgesic Gel Drug Industry Opportunities and Challenges
  4. 2.4 OTC Analgesic Gel Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global OTC Analgesic Gel Drug Market Perspective (2021-2032)
  2. 3.2 Global OTC Analgesic Gel Drug Growth Trends by Region
  3. 3.2.1 Global OTC Analgesic Gel Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global OTC Analgesic Gel Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global OTC Analgesic Gel Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global OTC Analgesic Gel Drug Revenue by Players
  2. 4.1.1 Global OTC Analgesic Gel Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global OTC Analgesic Gel Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global OTC Analgesic Gel Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global OTC Analgesic Gel Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global OTC Analgesic Gel Drug Key Players Headquarters & Area Served
  7. 4.4 Global OTC Analgesic Gel Drug Players, Product Type & Application
  8. 4.5 Global OTC Analgesic Gel Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global OTC Analgesic Gel Drug Market CR5 and HHI
  11. 4.6.3 2025 OTC Analgesic Gel Drug Tier 1, Tier 2, and Tier 3
5 OTC Analgesic Gel Drug Market Size by Type
  1. 5.1 Global OTC Analgesic Gel Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global OTC Analgesic Gel Drug Revenue by Type (2021-2032)
  3. 5.3 Global OTC Analgesic Gel Drug Revenue Market Share by Type (2021-2032)
6 OTC Analgesic Gel Drug Market Size by Application
  1. 6.1 Global OTC Analgesic Gel Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global OTC Analgesic Gel Drug Revenue by Application (2021-2032)
  3. 6.3 Global OTC Analgesic Gel Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 China Biopharmaceutical Co., Ltd.
  2. 7.1.1 China Biopharmaceutical Co., Ltd. Company Information
  3. 7.1.2 China Biopharmaceutical Co., Ltd. Business Overview
  4. 7.1.3 China Biopharmaceutical Co., Ltd. OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 China Biopharmaceutical Co., Ltd. OTC Analgesic Gel Drug Product Portfolio
  6. 7.1.5 China Biopharmaceutical Co., Ltd. Recent Developments
  7. 7.2 Jiangsu Innovent Biologics Co., Ltd.
  8. 7.2.1 Jiangsu Innovent Biologics Co., Ltd. Company Information
  9. 7.2.2 Jiangsu Innovent Biologics Co., Ltd. Business Overview
  10. 7.2.3 Jiangsu Innovent Biologics Co., Ltd. OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Jiangsu Innovent Biologics Co., Ltd. OTC Analgesic Gel Drug Product Portfolio
  12. 7.2.5 Jiangsu Innovent Biologics Co., Ltd. Recent Developments
  13. 7.3 Job Care Pharmaceutical Group Co., Ltd.
  14. 7.3.1 Job Care Pharmaceutical Group Co., Ltd. Company Information
  15. 7.3.2 Job Care Pharmaceutical Group Co., Ltd. Business Overview
  16. 7.3.3 Job Care Pharmaceutical Group Co., Ltd. OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Job Care Pharmaceutical Group Co., Ltd. OTC Analgesic Gel Drug Product Portfolio
  18. 7.3.5 Job Care Pharmaceutical Group Co., Ltd. Recent Developments
  19. 7.4 Hunan Jiudian Pharmaceutical Co., Ltd.
  20. 7.4.1 Hunan Jiudian Pharmaceutical Co., Ltd. Company Information
  21. 7.4.2 Hunan Jiudian Pharmaceutical Co., Ltd. Business Overview
  22. 7.4.3 Hunan Jiudian Pharmaceutical Co., Ltd. OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Hunan Jiudian Pharmaceutical Co., Ltd. OTC Analgesic Gel Drug Product Portfolio
  24. 7.4.5 Hunan Jiudian Pharmaceutical Co., Ltd. Recent Developments
  25. 7.5 Teikoku Pharma
  26. 7.5.1 Teikoku Pharma Company Information
  27. 7.5.2 Teikoku Pharma Business Overview
  28. 7.5.3 Teikoku Pharma OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Teikoku Pharma OTC Analgesic Gel Drug Product Portfolio
  30. 7.5.5 Teikoku Pharma Recent Developments
  31. 7.6 RB Health
  32. 7.6.1 RB Health Company Information
  33. 7.6.2 RB Health Business Overview
  34. 7.6.3 RB Health OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 RB Health OTC Analgesic Gel Drug Product Portfolio
  36. 7.6.5 RB Health Recent Developments
  37. 7.7 PERNATON
  38. 7.7.1 PERNATON Company Information
  39. 7.7.2 PERNATON Business Overview
  40. 7.7.3 PERNATON OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 PERNATON OTC Analgesic Gel Drug Product Portfolio
  42. 7.7.5 PERNATON Recent Developments
  43. 7.8 MIKASA SEIYAKU CO.,LTD
  44. 7.8.1 MIKASA SEIYAKU CO.,LTD Company Information
  45. 7.8.2 MIKASA SEIYAKU CO.,LTD Business Overview
  46. 7.8.3 MIKASA SEIYAKU CO.,LTD OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 MIKASA SEIYAKU CO.,LTD OTC Analgesic Gel Drug Product Portfolio
  48. 7.8.5 MIKASA SEIYAKU CO.,LTD Recent Developments
  49. 7.9 Lead Chemical CO., Ltd
  50. 7.9.1 Lead Chemical CO., Ltd Company Information
  51. 7.9.2 Lead Chemical CO., Ltd Business Overview
  52. 7.9.3 Lead Chemical CO., Ltd OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Lead Chemical CO., Ltd OTC Analgesic Gel Drug Product Portfolio
  54. 7.9.5 Lead Chemical CO., Ltd Recent Developments
  55. 7.10 Kowa Company
  56. 7.10.1 Kowa Company Company Information
  57. 7.10.2 Kowa Company Business Overview
  58. 7.10.3 Kowa Company OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Kowa Company OTC Analgesic Gel Drug Product Portfolio
  60. 7.10.5 Kowa Company Recent Developments
  61. 7.11 Haleon
  62. 7.11.1 Haleon Company Information
  63. 7.11.2 Haleon Business Overview
  64. 7.11.3 Haleon OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Haleon OTC Analgesic Gel Drug Product Portfolio
  66. 7.11.5 Haleon Recent Developments
8 North America
  1. 8.1 North America OTC Analgesic Gel Drug Revenue (2021-2032)
  2. 8.2 North America OTC Analgesic Gel Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America OTC Analgesic Gel Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America OTC Analgesic Gel Drug Revenue by Type (2027-2032)
  5. 8.3 North America OTC Analgesic Gel Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America OTC Analgesic Gel Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America OTC Analgesic Gel Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America OTC Analgesic Gel Drug Revenue by Application (2027-2032)
  9. 8.5 North America OTC Analgesic Gel Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America OTC Analgesic Gel Drug Revenue by Country
  11. 8.6.1 North America OTC Analgesic Gel Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America OTC Analgesic Gel Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America OTC Analgesic Gel Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe OTC Analgesic Gel Drug Revenue (2021-2032)
  2. 9.2 Europe OTC Analgesic Gel Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe OTC Analgesic Gel Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe OTC Analgesic Gel Drug Revenue by Type (2027-2032)
  5. 9.3 Europe OTC Analgesic Gel Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe OTC Analgesic Gel Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe OTC Analgesic Gel Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe OTC Analgesic Gel Drug Revenue by Application (2027-2032)
  9. 9.5 Europe OTC Analgesic Gel Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe OTC Analgesic Gel Drug Revenue by Country
  11. 9.6.1 Europe OTC Analgesic Gel Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe OTC Analgesic Gel Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe OTC Analgesic Gel Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China OTC Analgesic Gel Drug Revenue (2021-2032)
  2. 10.2 China OTC Analgesic Gel Drug Revenue by Type (2021-2032)
  3. 10.2.1 China OTC Analgesic Gel Drug Revenue by Type (2021-2026)
  4. 10.2.2 China OTC Analgesic Gel Drug Revenue by Type (2027-2032)
  5. 10.3 China OTC Analgesic Gel Drug Revenue Share by Type (2021-2032)
  6. 10.4 China OTC Analgesic Gel Drug Revenue by Application (2021-2032)
  7. 10.4.1 China OTC Analgesic Gel Drug Revenue by Application (2021-2026)
  8. 10.4.2 China OTC Analgesic Gel Drug Revenue by Application (2027-2032)
  9. 10.5 China OTC Analgesic Gel Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia OTC Analgesic Gel Drug Revenue (2021-2032)
  2. 11.2 Asia OTC Analgesic Gel Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia OTC Analgesic Gel Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia OTC Analgesic Gel Drug Revenue by Type (2027-2032)
  5. 11.3 Asia OTC Analgesic Gel Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia OTC Analgesic Gel Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia OTC Analgesic Gel Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia OTC Analgesic Gel Drug Revenue by Application (2027-2032)
  9. 11.5 Asia OTC Analgesic Gel Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia OTC Analgesic Gel Drug Revenue by Country
  11. 11.6.1 Asia OTC Analgesic Gel Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia OTC Analgesic Gel Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia OTC Analgesic Gel Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA OTC Analgesic Gel Drug Revenue (2021-2032)
  2. 12.2 SAMEA OTC Analgesic Gel Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA OTC Analgesic Gel Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA OTC Analgesic Gel Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA OTC Analgesic Gel Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA OTC Analgesic Gel Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA OTC Analgesic Gel Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA OTC Analgesic Gel Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA OTC Analgesic Gel Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA OTC Analgesic Gel Drug Revenue by Country
  11. 12.6.1 SAMEA OTC Analgesic Gel Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA OTC Analgesic Gel Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA OTC Analgesic Gel Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst